Literature DB >> 25008332

A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole.

Jharendra P Rijal1, Tiffany Pompa2, Smith Giri3, Vijaya Raj Bhatt4.   

Abstract

Toxic epidermal necrolysis (TEN) is a rare but serious dermatological emergency characterised by diffuse exfoliation of the skin and mucous membranes due to immune mediated destruction of the epidermis which can lead to sepsis and respiratory distress. Trimethoprim-sulfamethoxazole is a widely used antibiotic which can rarely lead to TEN. Early diagnosis and aggressive medical care is essential for the reduction of high morbidity and mortality associated with this disease. We present a case of successfully recovered TEN due to trimethoprim-sulfamethoxazole in a 62-year-old woman. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25008332      PMCID: PMC4091412          DOI: 10.1136/bcr-2013-203163

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  21 in total

Review 1.  Toxic epidermal necrolysis.

Authors:  P Wolkenstein; J Revuz
Journal:  Dermatol Clin       Date:  2000-07       Impact factor: 3.478

Review 2.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

Review 3.  Toxic epidermal necrolysis: review of pathogenesis and management.

Authors:  Andrew Downey; Chris Jackson; Nadia Harun; Alan Cooper
Journal:  J Am Acad Dermatol       Date:  2011-12-09       Impact factor: 11.527

4.  Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome.

Authors:  Riichiro Abe; Naoya Yoshioka; Junko Murata; Yasuyuki Fujita; Hiroshi Shimizu
Journal:  Ann Intern Med       Date:  2009-10-06       Impact factor: 25.391

Review 5.  Drug-induced toxic epidermal necrolysis.

Authors:  P E Wolkenstein; J C Roujeau; J Revuz
Journal:  Clin Dermatol       Date:  1998 May-Jun       Impact factor: 3.541

6.  Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?

Authors:  I Garcia-Doval; L LeCleach; H Bocquet; X L Otero; J C Roujeau
Journal:  Arch Dermatol       Date:  2000-03

7.  Trimethoprim-sulfamethoxazole-induced Stevens-Johnson syndrome: a case report.

Authors:  Michael R Langlois; Francis Derk; Ronald Belczyk; Thomas Zgonis
Journal:  J Am Podiatr Med Assoc       Date:  2010 Jul-Aug

Review 8.  Toxic epidermal necrolysis (Lyell's disease).

Authors:  Mario Lissia; Pietro Mulas; Antonio Bulla; Corrado Rubino
Journal:  Burns       Date:  2009-09-18       Impact factor: 2.744

9.  The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).

Authors:  J C Guillaume; J C Roujeau; J Revuz; D Penso; R Touraine
Journal:  Arch Dermatol       Date:  1987-09

10.  Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.

Authors:  S Bastuji-Garin; B Rzany; R S Stern; N H Shear; L Naldi; J C Roujeau
Journal:  Arch Dermatol       Date:  1993-01
View more
  1 in total

1.  Early Manifestations of Toxic Epidermal Necrolysis.

Authors:  James Chapman; Katy Deblois
Journal:  Clin Pract Cases Emerg Med       Date:  2017-10-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.